Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study

The epidermal growth factor receptor (EGFR) and its ligands are involved in cancer pathogenesis and they might serve as circulating biomarkers. The current study aims to investigate if abnormal pre-treatment serum levels of EGFR and EGFR ligands are present in women with early-stage breast cancer an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjær, Ina Mathilde, Olsen, Dorte Aalund, Brandslund, Ivan, Bechmann, Troels, Jakobsen, Erik Hugger, Bogh, Søren Bie, Madsen, Jonna Skov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174424/
https://www.ncbi.nlm.nih.gov/pubmed/32317675
http://dx.doi.org/10.1038/s41598-020-63375-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174424/
https://www.ncbi.nlm.nih.gov/pubmed/32317675
http://dx.doi.org/10.1038/s41598-020-63375-z

Ejemplares similares